Yahoo
    ASX - Delayed Quote AUD

    Lumos Diagnostics Holdings Limited (LDX.AX)

    0.0600 0.0000 (0.00%)
    At close: November 6 at 4:10:28 PM GMT+11
    Loading Chart for LDX.AX
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Lumos Diagnostics expands FebriDx US rollout as quarterly product revenue jumps 224%

    Lumos Diagnostics expands FebriDx US rollout as quarterly product revenue jumps 224%
    Proactive 11d ago
    Lumos Diagnostics to provide US FebriDx update at quarterly results briefing

    Lumos Diagnostics to provide US FebriDx update at quarterly results briefing
    Proactive 19d ago
    Lumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace

    Lumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace
    Proactive 3mo ago
    Lumos Diagnostics expands FebriDx reach into Romania through Alpha Medical distribution deal

    Lumos Diagnostics expands FebriDx reach into Romania through Alpha Medical distribution deal
    Proactive 3mo ago
    Lumos Diagnostics caps FY26 with FebriDx revenue up 875% and US rollout gaining momentum

    Lumos Diagnostics caps FY26 with FebriDx revenue up 875% and US rollout gaining momentum
    Proactive 3mo ago
    Lumos Diagnostics secures 30-site FebriDx rollout across major US urgent care networks

    Lumos Diagnostics secures 30-site FebriDx rollout across major US urgent care networks
    Proactive 3mo ago
    Lumos Diagnostics receives A$710,000 R&D tax rebate to support point-of-care technology development

    Lumos Diagnostics receives A$710,000 R&D tax rebate to support point-of-care technology development
    Proactive 4mo ago
    Lumos sees strong early reimbursement signals as FebriDx® rollout gains traction in US urgent care market

    Lumos sees strong early reimbursement signals as FebriDx® rollout gains traction in US urgent care market
    Proactive 5mo ago
    Lumos hits major US regulatory milestone with FebriDx study support

    Lumos hits major US regulatory milestone with FebriDx study support
    Proactive 5mo ago
    Lumos receives US$500,000 BARDA milestone payment as FebriDx rollout accelerates

    Lumos receives US$500,000 BARDA milestone payment as FebriDx rollout accelerates
    Proactive 5mo ago
    Lumos Diagnostics expands FebriDx rollout to 215 US sites

    Lumos Diagnostics expands FebriDx rollout to 215 US sites
    Proactive 1mo ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: